333 related articles for article (PubMed ID: 7812673)
21. Mechanisms underlying the inhibitory actions of the pentacyclic triterpene alpha-amyrin in the mouse skin inflammation induced by phorbol ester 12-O-tetradecanoylphorbol-13-acetate.
Medeiros R; Otuki MF; Avellar MC; Calixto JB
Eur J Pharmacol; 2007 Mar; 559(2-3):227-35. PubMed ID: 17258194
[TBL] [Abstract][Full Text] [Related]
22. Lyprinol inhibits LTB4 production by human monocytes.
Dugas B
Allerg Immunol (Paris); 2000 Sep; 32(7):284-9. PubMed ID: 11094642
[TBL] [Abstract][Full Text] [Related]
23. BAY X1005, a new inhibitor of leukotriene synthesis: in vivo inflammation pharmacology and pharmacokinetics.
Müller-Peddinghaus R; Kohlsdorfer C; Theisen-Popp P; Fruchtmann R; Perzborn E; Beckermann B; Bühner K; Ahr HJ; Mohrs KH
J Pharmacol Exp Ther; 1993 Oct; 267(1):51-7. PubMed ID: 8229782
[TBL] [Abstract][Full Text] [Related]
24. Identification of 4-[4-(4-fluoro-phenyl)-thiazol-2-ylamino]-2,6-dimethyl-phenol (KR-33749) as an inhibitor of 5-lipoxygenase with potent antiinflammatory activity.
Cho YS; Kim CH; Surh JH; Kang NS; Yoo SE; Cheon HG
Pharmacology; 2010; 86(2):65-72. PubMed ID: 20639685
[TBL] [Abstract][Full Text] [Related]
25. Anti-inflammatory effect of YPE-01, a novel diarylheptanoid derivative, on dermal inflammation in mice.
Yamazaki R; Aiyama R; Matsuzaki T; Hashimoto S; Yokokura T
Inflamm Res; 1998 Apr; 47(4):182-6. PubMed ID: 9628261
[TBL] [Abstract][Full Text] [Related]
26. Role of 5-lipoxygenase products in the local accumulation of neutrophils in dermal inflammation in the rabbit.
Marleau S; Fruteau de Laclos B; Sanchez AB; Poubelle PE; Borgeat P
J Immunol; 1999 Sep; 163(6):3449-58. PubMed ID: 10477617
[TBL] [Abstract][Full Text] [Related]
27. Effect of topically applied cyclooxygenase-2-selective inhibitors on arachidonic acid- and tetradecanoylphorbol acetate-induced dermal inflammation in the mouse.
Puigneró V; Queralt J
Inflammation; 1997 Aug; 21(4):431-42. PubMed ID: 9276765
[TBL] [Abstract][Full Text] [Related]
28. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory action of orally active 5-lipoxygenase inhibitor TMK688.
Yamamoto S; Jiang H; Kato R
Pharmacology; 1994 May; 48(5):273-82. PubMed ID: 8016188
[TBL] [Abstract][Full Text] [Related]
30. Pre-clinical pharmacology of ICI D2138, a potent orally-active non-redox inhibitor of 5-lipoxygenase.
McMillan RM; Spruce KE; Crawley GC; Walker ER; Foster SJ
Br J Pharmacol; 1992 Dec; 107(4):1042-7. PubMed ID: 1334748
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological investigation of the role of leukotrienes in the pathogenesis of experimental NSAID gastropathy.
Vaananen PM; Keenan CM; Grisham MB; Wallace JL
Inflammation; 1992 Jun; 16(3):227-40. PubMed ID: 1323529
[TBL] [Abstract][Full Text] [Related]
32. ASB16165, a phosphodiesterase 7A inhibitor, reduces cutaneous TNF-alpha level and ameliorates skin edema in phorbol ester 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation model in mice.
Kadoshima-Yamaoka K; Goto M; Murakawa M; Yoshioka R; Tanaka Y; Inoue H; Murafuji H; Kanki S; Hayashi Y; Nagahira K; Ogata A; Nakatsuka T; Fukuda Y
Eur J Pharmacol; 2009 Jun; 613(1-3):163-6. PubMed ID: 19379723
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation.
Lorrain DS; Bain G; Correa LD; Chapman C; Broadhead AR; Santini AM; Prodanovich P; Darlington JV; Hutchinson JH; King C; Lee C; Baccei C; Li Y; Arruda JM; Evans JF
J Pharmacol Exp Ther; 2009 Dec; 331(3):1042-50. PubMed ID: 19749079
[TBL] [Abstract][Full Text] [Related]
34. The effect of a novel, dual function histamine H1 receptor antagonist/5-lipoxygenase enzyme inhibitor on in vivo dermal inflammation and extravasation.
Giannaras A; Selig W; Ellis J; Hullinger T
Eur J Pharmacol; 2005 Jan; 506(3):265-71. PubMed ID: 15627437
[TBL] [Abstract][Full Text] [Related]
35. (E)-3-[6-[[(2,6-dichlorophenyl)thio]methyl]-3-(2-phenylethoxy)-2- pyridinyl]-2-propenoic acid: a high-affinity leukotriene B4 receptor antagonist with oral antiinflammatory activity.
Daines RA; Chambers PA; Foley JJ; Griswold DE; Kingsbury WD; Martin LD; Schmidt DB; Sham KK; Sarau HM
J Med Chem; 1996 Sep; 39(19):3837-41. PubMed ID: 8809171
[TBL] [Abstract][Full Text] [Related]
36. The role of endogenous eicosanoids in rabbit-intraocular inflammation.
Kulkarni PS
J Ocul Pharmacol; 1991; 7(3):227-41. PubMed ID: 1664445
[TBL] [Abstract][Full Text] [Related]
37. Effect of a leukotriene B4 receptor antagonist SC-53228 on ozone-induced airway hyperresponsiveness and inflammation in dogs.
Stevens WH; Vanderheyden C; Wattie J; Lane CG; Smith W; O'Byrne PM
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1443-8. PubMed ID: 7582275
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of Leukotriene B4 Action Mitigates Intracerebral Hemorrhage-Associated Pathological Events in Mice.
Hijioka M; Anan J; Ishibashi H; Kurauchi Y; Hisatsune A; Seki T; Koga T; Yokomizo T; Shimizu T; Katsuki H
J Pharmacol Exp Ther; 2017 Mar; 360(3):399-408. PubMed ID: 28035009
[TBL] [Abstract][Full Text] [Related]
39. Leukotriene B4-induced granulocyte trafficking in guinea pig dermis. Effect of second-generation leukotriene B4 receptor antagonists, SC-50605 and SC-51146.
Fretland DJ; Widomski DL; Anglin CP; Penning TD; Yu S; Djuric SW
Inflammation; 1993 Jun; 17(3):353-60. PubMed ID: 8392493
[TBL] [Abstract][Full Text] [Related]
40. Effects of tepoxalin, a dual inhibitor of cyclooxygenase/5-lipoxygenase, on events associated with NSAID-induced gastrointestinal inflammation.
Kirchner T; Aparicio B; Argentieri DC; Lau CY; Ritchie DM
Prostaglandins Leukot Essent Fatty Acids; 1997 Jun; 56(6):417-23. PubMed ID: 9223651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
